Clinical Trial Update: Oral Salt and Water to Prevent Contrast Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating oral salt and water to prevent contrast-induced nephropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Acute Kidney Injury | Phase 4 | Status: WITHDRAWN